Accounts Submission


DERMOSCOPY UK LIMITED

Company Registration Number:
05213637 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

DERMOSCOPY UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

DERMOSCOPY UK LIMITED

Company Information

for the Period Ended 31 March 2023




Director: Dr Jonathan Bowling
Annabel Bowling
Registered office: Brookleigh
Milley Road
Waltham St. Lawrence
Reading
England
RG10 0JR
Company Registration Number: 05213637 (England and Wales)

DERMOSCOPY UK LIMITED

Directors' Report Period Ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Principal Activities

The principal activity of the company in the year under review was that of medical education and dermatology.

Directors

The directors shown below have held office during the whole of the period from 01 April 2022 to 31 March 2023
Dr Jonathan Bowling
Annabel Bowling

This report was approved by the board of directors on 5 June 2023
And Signed On Behalf Of The Board By:

Name: Dr Jonathan Bowling
Status: Director

DERMOSCOPY UK LIMITED

Balance sheet

As at 31 March 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 15,000 17,662
Total fixed assets: 15,000 17,662
Current assets
Debtors: 10,743 26,676
Cash at bank and in hand: 496,155 452,442
Total current assets: 506,898 479,118
Creditors: amounts falling due within one year: ( 125,809 ) ( 117,562 )
Net current assets (liabilities): 381,089 361,556
Total assets less current liabilities: 396,089 379,218
Total net assets (liabilities): 396,089 379,218

The notes form part of these financial statements

DERMOSCOPY UK LIMITED

Balance sheet continued

As at 31 March 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 106 106
Profit and loss account: 395,983 379,112
Shareholders funds: 396,089 379,218

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 5 June 2023
And Signed On Behalf Of The Board By:

Name: Dr Jonathan Bowling
Status: Director

The notes form part of these financial statements

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 2 3

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 3. Off balance sheet disclosure

    No

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Tangible Assets

Total
Cost £
At 01 April 2022 63,386
Additions -
Disposals -
Revaluations -
Transfers -
At 31 March 2023 63,386
Depreciation
At 01 April 2022 45,724
Charge for year 2,662
On disposals -
Other adjustments -
At 31 March 2023 48,386
Net book value
At 31 March 2023 15,000
At 31 March 2022 17,662